Stressgen (VSE: SSB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: brent groh who wrote (1)	7/26/1996 1:04:00 PM
From: Andy Patton	of 236

Howdy: I noticed that when Nesbitt Burns looked at it, they pointed out that Stessgen would have to conclude some sort of agreement with gene therapy patent holders so that no-one could could get around Stressgen by gene-splicing stress proteinss, and Streesgen's recent agreement with the the Medical Research Council in London for their gene-splicing rights does exactly this. So now, anyone wanting to use Stress Proteins for medical work has to go through Stressgen. Their stock is down recently, but it looks to me as though they're actually in a much stronger position than they were. -Andy Patton

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next